News
Schering CEO told study results days before public | Reuters
www.reuters.com
Schering-Plough Corp's chief executive learned the results of a controversial study involving its big-selling cholesterol drug four days before the company...
Thomas P. Koestler, Ph.D., Elected Head of Schering-Plough R&D
www.finanznachrichten.de
KENILWORTH, N.J., Sept PRNewswire/ -- Schering-Plough Corporation announced today that its Board of Directors has elected Thomas P. Koestler, Ph.D., as...
Clinical ops gets a facelift at Schering-Plough - PharmaTimes
www.pharmatimes.com
Schering-Plough has continued the overhaul of its business practices started prompted by chief executive Fred Hassan with a revamp of its clinical research...
메디포뉴스
medifonews.com
... 바이토린(Vytorin)에 심각한 부작용은 없으며 간 안전성에 대한 표시된 정보에 회사가 자신감을 갖고 있다고 R&D 총 책임자 코스틀러(Tom Koestler)씨가 주장했다. › news › ar...
sortiert nach Relevanz / Datum